Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins-Reference-Cited by-同舟云学术

Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins

Published:2019-04-24 Issue:2 Volume:4 Page:
ISSN:2379-5042
Container-title:mSphere
language:en
Short-container-title:mSphere

Author:

Schepp Rutger M.¹,de Haan Cornelis A. M.²,Wilkins Deidre³,Layman Hans³,Graham Barney S.⁴,Esser Mark T.³,Berbers Guy A. M.¹

Affiliation:

1. Center of Infectious Disease Control, National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands

2. Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands

3. AstraZeneca, Gaithersburg, Maryland, USA

4. Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

Abstract

In view of vaccine and monoclonal development to reduce hospitalization and death due to lower respiratory tract infection caused by RSV, assessment of antibody levels against RSV is essential. This newly developed multiplex immunoassay is able to measure antibody levels against five RSV proteins simultaneously. This can provide valuable insight into the dynamics of (maternal) antibody levels and RSV infection in infants and toddlers during the first few years of life, when primary RSV infection occurs.

Publisher

American Society for Microbiology

Subject

Molecular Biology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mSphere.00236-19

Reference28 articles.

1. Clinical and Epidemiologic Features of Respiratory Syncytial Virus

2. Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis

3. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

4. Respiratory syncytial virus protein structure, function and implications for subunit vaccine development

5. Translational sciences approach to RSV vaccine development

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virus neutralization assays for human respiratory syncytial virus using airway organoids;Cellular and Molecular Life Sciences;2024-06-17

2. Development and validation of a respiratory syncytial virus multiplex immunoassay;Infection;2024-02-08

3. Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands;Vaccines;2023-12-02

4. Development and validation of a respiratory syncytial virus multiplex immunoassay;2023-09-01

5. Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adults;Clinical and Experimental Immunology;2023-08-22